In our RPL10 R98S model, it can be hypothesized that cells might be sensitive to palbociclib-induced activation of PFKP and PKM2 to counteract the enhanced expression and activity of the PSPH-driven serine synthesis in this T-ALL subset. Here, RPL10 is linked to acute lymphoblastic leukemia.